A big opioid settlement and a COVID-19 vaccine slowdown dragged on third-quarter earnings for Walgreens.
Tom Murphy, Chicago Tribune: Business
Thu, 06/30/2022 - 10:39am
A big opioid settlement and a COVID-19 vaccine slowdown dragged on third-quarter earnings for Walgreens.